MedTech Spectrum

Article Name Clinical & Diagnostic

Stockholm's Hermes Medical Solutions and Spectrum Dynamics Medical partner up

To offer an integrated solution of the Hermia software with the Veriton-CT scanner

29th April, 2024

Scientists in Singapore develop wearable sensor to measure real skin feel

Allowing rigorous assessment of the touch sensory experience

19th April, 2024

Dräger Launches Vista 300 in India, Transforming Hospital Information Systems with Advanced Patient Monitoring

Dräger, a global leader in medical and safety technology, announces the launch of Vista 300 in India, a groundbreaking patient monitoring system designed to streamline information flow across hospital departments

16th April, 2024

Institute of Heart & Lung Diseases partners with Krafton India for active TB cases detection

To screen approximately 1 lakh individuals over the next 12 months

08th April, 2024

Taiwan develops world's first AI-powered sepsis alert system

To assist physicians in the early identification of patients at higher bacteremia risk

04th April, 2024

Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo

Cognizant's AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors

20th March, 2024

ScreenPoint Medical deploys Transpara® Breast AI at Johns Hopkins to improve cancer detection

Implementation of Transpara for clinical use by key opinion leaders in radiology and breast imaging.

13th March, 2024

China-based medtech firm Zylox-Tonbridge partners with Avinger in US for vascular disease diagnosis

Zylox-Tonbridge to invest $15 million into Avinger in two tranches

13th March, 2024

Zidebactam/Cefepime (ZaynichTM) successful in renal transplant patient with extreme-drug resistant Pseudomonas infection

Promising treatment for extreme-drug resistant Pseudomonas infection in renal transplant patients"

12th March, 2024

Apollo Hospital in New Delhi Initiates First Non-Invasive ZAP-X Brain Tumor Treatment in South Asia

Milestone Reinforces Mutual Commitment to Advancing Healthcare Through Greater Access to State-of-the-Art Medical Technologies

08th March, 2024

Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon

First coronary drug-coated balloon in U.S. provides safe, effective alternative to treat coronary in-stent restenosis and reduce risk of reoccurrence

06th March, 2024

Fujifilm unveils Echelon Synergy MRI Machine in India

A game-changer in healthcare technology with unparalleled performance

05th March, 2024

Medidata and Sanofi Vaccine partners to enable remote patient monitoring with real-time data collection

The collaboration will deploy Medidata Electronic Clinical Outcomes Assessment (eCOA) to create an electronic diary database dedicated to Sanofi vaccines

01st March, 2024

Medtronic announces expansion of Engineering & Innovation Center in Hyderabad

Medtronic Engineering and Innovation Center is Medtronic’s largest R&D centre outside the US

01st March, 2024

Frederick Health Teams Up with MEDITECH and GenomOncology to Propel Precision Medicine Forward

A Tripartite Alliance for Advancing Precision Healthcare at Frederick Health

29th February, 2024

KARL STORZ is First to Market with Alexa in the Operating Room

Voice-activated control in the surgical suite is designed to increase efficiency and patient focus.

28th February, 2024

“Early diagnosis through advanced screening tech, coupled with heightened awareness is crucial”

The oncology market in India is steadily growing, driven by an increasing cancer incidence and a strong demand for advanced treatments. However, there remains substantial untapped potential, primarily in improving access to cutting-edge therapies and expanding reach to underserved regions. Glenmark Pharma, with its patient-centric approach and innovative solutions, has been steadily increasing its market share by introducing high-quality and affordable cancer drugs. Alok Malik, President & Business Head - India Formulations, Glenmark Pharmaceuticals Ltd, in an exclusive interview with MedTech Spectrum & BioSpectrum, spoke at length about the company’s mission to enhance access to high-quality cancer care in India and the untapped market potential, new launches and the plans ahead.

28th February, 2024

Refocusing on Rare Diseases

The US Food and Drug Administration (FDA) approval in December 2023, of two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of a rare disease called sickle cell disease (SCD) in patients 12 years and older, is a huge development. With rare diseases posing significant challenges due to the scarcity of information, limited research, and insufficient awareness among healthcare professionals and the public, introduction and approval of specific treatments can provide a much needed boost to tackle the growing burden of rare diseases globally. However, an integrated approach with enhanced coordination and cooperation across the ecosystem is the need of the hour.

28th February, 2024